Navigation Links
Macugen drug for treating degenerative eye disease

The drug Macugen is found to be effective in treating wet age related macular degeneration disease which is a progressive disease// of the macula. Wet age related macular degeneration is caused due to a chronic degenerative disease of the macula region of the eye, macula is present in the retina which is responsible for proper eye sight.

The degenerative disease is caused by the growth of abnormal blood vessel beneath the macula which leads to severe bleeding and accumulation of fluid in retina leading to a condition called Choroidal neovascularization. The new drug Macugen, which is manufactured by Pfizer and OSI Pharmaceuticals, is found to be very effective in treating this degenerative disease by preserving the visual integrity of the macula, the drug is found to stop bleeding and accumulation of fluid in the retina and is found to be very effective than other treatment procedures offered to cure eye disease.


'"/>




Page: 1

Related medicine news :

1. Eye Drug Macugen Shows Allergic Reactions
2. Gene Therapy shows promise in treating Hemophilia
3. Ketoconazole 2% more effective in treating Seborrheic Dermatitis
4. Diuretics are better for treating blood pressure problems than newer medicines
5. A ray of hope in treating blindness and other eye disorders
6. Child Friendly Zidovudine Preparation for treating HIV infection Approved By The FDA
7. Surgeons in India to Mend ‘Pakistani Hearts’ by treating 70 Childrn
8. Weight reduction by 5% may help in treating nonalcoholic fatty liver disease
9. Lower doses of oral contraceptives helpful in treating acne
10. Systemic Corticosteroid Therapy can be used for treating all types of Infectious Mononucleosis
11. Novel Actemra monotherapy in treating patients with early aggressive rheumatoid arthritis
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:6/27/2016)... Lafayette, California (PRWEB) , ... ... ... a pioneer in the patient payment industry today announced its strategic partnership ... and health system workflows. , The two companies’ proven, proprietary technology combine ...
(Date:6/26/2016)... ... June 27, 2016 , ... Quality metrics are proliferating in cancer ... they remain in the eye of the beholder, according to experts who offered insights ... American Journal of Managed Care. For the full issue, click here . , ...
(Date:6/26/2016)... North Carolina (PRWEB) , ... June 26, 2016 , ... ... release of a new product that was developed to enhance the health of felines. ... for centuries. , The two main herbs in the PawPaws Cat Kidney Support ...
(Date:6/25/2016)... ... June 25, 2016 , ... ... and applications at AcademyHealth’s Annual Research Meeting June 26-28, 2016, at the Hynes ... important health care topics including advance care planning, healthcare costs and patient and ...
(Date:6/25/2016)... ... June 25, 2016 , ... "With 30 hand-drawn hand gesture animations, ... Christina Austin - CEO of Pixel Film Studios. , ProHand Cartoon’s package transforms ... Final Cut Pro X . Simply select a ProHand generator and drag it above ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... , June 23, 2016  MedSource announced today ... its e-clinical software solution of choice.  This latest ... possible value to their clients by offering a ... preferred relationship establishes nowEDC as the EDC platform ... MedSource,s full-service clients.  "nowEDC has long been a ...
(Date:6/23/2016)... Any dentist who has made an implant supported ... Many of them do not even offer this as a ... laboratory costs involved. And those who ARE able to offer ... high cost that the majority of today,s patients would not ... Zadeh , founder of Dental Evolutions Inc. and inventor of ...
(Date:6/23/2016)... startling report released today, National Safety Council research shows ... plan to eliminate prescription opioid overdoses. Prescription Nation ... the worst drug crisis in recorded U.S. history, assigned a "Making ... , New Mexico , Tennessee ... states, three – Michigan , Missouri ...
Breaking Medicine Technology: